The blood coagulation factor market is experiencing consistent growth due to the increasing prevalence of bleeding disorders, advancements in recombinant therapies, and rising awareness regarding early diagnosis and treatment. Blood coagulation factors are essential therapeutic products used to manage inherited and acquired coagulation disorders, particularly hemophilia and other rare bleeding...

"Future of Executive Summary Saudi Arabia, Turkey, and Egypt Immunohematology Market: Size and Share Dynamics CAGR Value The Saudi Arabia, Turkey, and Egypt Immunohematology market size was valued at USD 797.6, 418.1, 225.0 million in 2024 and is expected to reach USD 1074.89, 581.06, 285.02 million by 2032, at a CAGR of 3.8%, 4.2% and 3.0% during the forecast period The Saudi Arabia,...